Reading · #AutisticAF Out Loud Newsletter

The Facts: The Interagency Autism Coordinating Committee’s public comment period on its 2026-2028 Strategic Plan, the document that will guide federal autism research priorities at NIH, CDC, and other agencies, closes August 20 at 5 p.m. ET (Beckers Behavioral Health). The panel originally gave the public just days to review a 336-page draft released July 20 before advocacy pressure forced a 30-day extension (Disability Scoop).

Advocacy groups say the draft proposes 357 million dollars in new funding, including a 57 million dollar line for neurodevelopmental regression research. “Profound autism” appears 45 times in the text. It received no dedicated funding line of its own (Profound Autism Alliance).

The Impact: The plan will steer two years of federal autism research spending. It will shape research on autism causes, treatments, and support needs.

Advocates for people with profound autism flag a funding gap. The term, coined by a 2021 Lancet Commission, describes autistic people who are nonverbal or minimally verbal, have IQs below 50, and require lifelong 24/7 care. Advocates argue their needs may stay underfunded even though the plan names them (AP News, Profound Autism Alliance).

The Context/Blindspot: “Profound autism” is not a separate DSM-5 diagnosis. It remains a contested research and policy term.

The Autistic Self Advocacy Network and much of the broader neurodiversity movement oppose the term. They argue it revives deficit-based framing, risks segregating autistic people by perceived severity, and could weaken civil-rights protections for people it describes (Autistic Self Advocacy Network, PBS NewsHour).

Groups like the Profound Autism Alliance and the National Council for Severe Autism argue the reverse. They say one broad spectrum label erases the people with the most intensive support needs from research and policy attention (AP News).

The IACC’s current push toward formalizing the term under HHS Secretary Robert F. Kennedy Jr.’s leadership has intensified this fight. Federal research funding now carries real weight in a debate the community itself has not settled (Bridgette Hamstead). Mainstream coverage of the funding gap has largely treated “profound autism” as a settled clinical category rather than naming this unresolved dispute.

The Facts: A study published August 12 in the New England Journal of Medicine found leucovorin prescriptions for children rose sharply after a September 2025 White House press conference promoted the drug as a possible autism treatment. Prescriptions climbed from 4.6 to 8.0 per 100,000 children by the end of the study period, a 46 percent jump immediately after the announcement (CIDRAP).

Leucovorin is FDA-approved only for a rare condition called cerebral folate deficiency, not autism broadly. The largest clinical trial supporting its use for autism was retracted in February 2026 after a data review found unreproducible errors (The Transmitter).

The Impact: Lead author Kao-Ping Chua said the press conference likely drove off-label prescribing to autistic children despite uncertain effectiveness and unknown long-term safety (CIDRAP). The findings raise questions about how much influence federal health messaging can have on prescribing patterns independent of peer-reviewed evidence.

The Context/Blindspot: The study measured prescriptions, not health outcomes. It cannot show if the drug helped, harmed, or did nothing for children who took it.

Coverage has focused on the prescribing increase. It has not answered what oversight federal health agencies plan for off-label promotion after a discredited trial (CIDRAP).

Validity Scorecard:

Sample Size/Demographics: The study used a national pharmacy database. It tracked prescriptions for millions of children. That scale makes the prescribing trend more reliable. It does not show how the drug worked for individual children. Rising prescriptions do not prove that leucovorin works (CIDRAP).
Funding Source: Available coverage did not disclose funding. This matters because readers cannot assess whether drug makers, government agencies, or advocacy groups shaped the study’s design or framing.
Journal Reliability: The study appeared in the New England Journal of Medicine. It is a major, high-impact peer-reviewed journal. That supports confidence in its methods and review.
ND Involvement: Not disclosed. There is no indication autistic people helped design the study. There is also no sign they helped interpret the prescribing rise. That leaves out community input on how the paper frames off-label use and treatment demand.
Observed Weaknesses: The study measures prescribing, not clinical outcomes. It cannot show whether leucovorin helped, harmed, or had no effect. That gap matters after the earlier trial was retracted. Readers should not treat rising prescriptions as proof that the drug works.

The Facts: Caroline Stevens said August 18 that she will leave as Chief Executive of the National Autistic Society. She has led the U.K.’s largest autism charity for nearly seven years (National Autistic Society).

Stevens has an autistic son. She said she wants to spend more time supporting family, including her son and young grandchild. She did not cite an organizational crisis (National Autistic Society).

Board chair Steve Ladyman said Stevens leaves the charity “in a much stronger position.” The board has begun a search for her successor (National Autistic Society).

The Impact: The National Autistic Society is the U.K.’s main autism advocacy and service group. Its leadership change comes after the nation’s autism strategy expired in July. The government has not confirmed a replacement (Autistica).

Autistic people and families use the charity’s diagnosis support, helplines, and policy work. The change comes while the wider autism-services plan remains unsettled.

The Context/Blindspot: Coverage centers Stevens’s personal statement. It says less about unfinished policy work. That includes the charity’s criticism of National Health Service plans on autism-assessment waits (National Autistic Society).

No public timeline or shortlist exists for her replacement.

See a story we missed? See Tips & Submissions below.

The Facts: A 12-year-old autistic girl was reported missing from a Joplin home on August 9. More than 50 volunteers searched before police found her nearby (Yahoo News).

Court documents allege she was locked in a padlocked, zip-tied dog kennel almost every night. The alleged confinement lasted up to two years (Yahoo News).

She weighed about 50 pounds. She had not attended school in at least five years (Yahoo News).

Her adoptive parents, Crystal Ross, 46, and Shane Ross, 50, face felony child abuse or neglect charges. Adoptive sisters Hannah Ross, 25, and Megan Ross, 19, also face charges. All four also face misdemeanor animal neglect counts (Yahoo News).

On August 13, all four entered not-guilty pleas. They remain jailed without bond. Their next court date is August 26 (Newstalk KZRG).

The Impact: The girl is in protective custody and getting medical care (Newstalk KZRG).

Cases like this can surface only after a crisis. A missing-person report may trigger contact that school, health, or child-welfare systems missed.

Nonverbal autistic children, or children needing high support, can be isolated for years. People outside the home may not see the abuse.

The Context/Blindspot: Local Joplin outlets have driven most reporting on this case (KOAM News Now, KOAM News Now).

Police say the investigation remains open. More charges are possible. Current coverage does not say whether the child saw a pediatrician, school liaison, or caseworker during the alleged two-year period.

The Facts: Irvine police released body-worn camera footage August 15. It showed the July 21 shooting death of Daniel Meltvedt, 20 (New York Post).

Meltvedt was autistic. He called 911 during a mental health crisis (New York Post).

The video shows officers negotiating with Meltvedt for about an hour. He said he had stopped taking an antipsychotic medication. He also said he was suicidal (New York Post).

Meltvedt then ran at officers while holding a kitchen knife. Two officers fired eight shots. Paramedics pronounced him dead at a hospital (Orange County Register, New York Post).

The Impact: The footage puts focus back on police responses to crisis calls. Meltvedt had called for help.

His family remains critical of the department’s response. They have questioned why police used lethal force (Orange County Register).

The Context/Blindspot: Irvine Police and the Orange County District Attorney’s Office are investigating the shooting. No findings were released this week (Orange County Register).

Coverage has focused on the video. It has not said what crisis-intervention training officers had. It also has not said whether less-lethal options were available.

The Facts: A Richland, Washington court sentenced Lisa M. Foster, 42, to 10 months in jail on August 17. She entered an Alford plea to third-degree assault of a child (Tri-City Herald).

The case involved her 7-year-old autistic son. He was found with bruising around his eye and mouth in January. Foster told investigators she was trying to keep him quiet at night (Tri-City Herald).

Court records describe two earlier substantiated abuse findings involving the same child. In 2023, he suffered two broken leg bones. Doctors called the injuries “high force blunt trauma” (Tri-City Herald).

The Impact: The judge cited Foster’s decade-long history of neglect and abuse findings. The court also renewed a no-contact order (Tri-City Herald).

Repeated child-welfare action did not stop further harm. The child was nonverbal or had limited communication. He struggled to tell others what happened to him.

The Context/Blindspot: Tri-Cities crime reporters, not national outlets, tracked this case through sentencing (Tri-City Herald).

Coverage does not say whether child-welfare workers offered Foster specialized support. She was in a substance-treatment program. The support question matters because she was parenting an autistic child after earlier substantiated findings.

See a story we missed? See Tips & Submissions below.

Editor’s note: Missing-person cases change status fast. Check local alert systems before relying on any case detail here.

Fairfax County Police issued a missing and endangered person alert August 16 for Juan Hernandez Garcia, 19. He was last seen near Bailey’s Crossroads about 11:45 p.m. the night before (Fairfax County Police Department).

Police said health concerns put him at risk. They released his height, weight, and physical description (X/Fairfax County Police). He was found safe later that day (Fairfax County Police Department).

No other new missing-autistic-person cases from the past 72 hours appeared in this cycle’s local and regional searches.

See a story we missed? See Tips & Submissions below.

The Facts: Assembly Bill 2233, by Assemblyman Tri Ta, moved through the state Senate this month. It was read a second time on August 10. That moves it closer to a final vote before the session ends (California Digital Democracy).

The bill would stop health plans from restricting already-authorized autism treatment hours during a six-month authorization period (Legiscan).

The Impact: Families using Applied Behavior Analysis therapy can lose treatment hours already approved. A plan may impose new limits during an authorization period.

AB 2233 would protect approved hours for six months. The hours still must match a child’s treatment plan. The change could reduce sudden gaps in care (Assemblyman Tri Ta’s office).

The Context/Blindspot: The bill passed the Assembly unanimously. It moved through Senate committees with little visible opposition. Most coverage comes from the author’s office and bill-tracking sites, not independent statehouse reporting (Citizen Portal).

It is not clear when the final Senate vote will happen. Governor Newsom has not stated a position.

The Facts: North Carolina’s updated Medicaid policy for autism behavior therapy took effect August 1. House Bill 696 required the changes. The policy is still in its first weeks (AutismCOE).

The rules require more reauthorization for high-intensity plans. They add caregiver-training requirements and credentialing deadlines for behavior technicians. Most out-of-state providers cannot bill North Carolina Medicaid (BH Business).

The Impact: State officials say the changes are not a blanket cut to ABA coverage. But families now face more frequent medical-necessity reviews (AutismCOE).

More than half the state’s certified workforce may rely on out-of-state board-certified behavior analysts, according to earlier reporting. Those providers now face billing restrictions.

The Context/Blindspot: North Carolina’s Department of Health and Human Services has not released detailed early data. It has not said how many families or providers the August 1 rules have affected.

Local and specialty outlets have done most reporting on the rollout (North Carolina Health News).

The Facts: A new study followed 125 children with tuberous sclerosis complex for 10 years. Tuberous sclerosis complex is a rare genetic disorder. It causes benign tumors in several organs (The Transmitter).

Forty percent of the children received an autism diagnosis (The Transmitter).

Autism diagnosis was linked to more cortical tubers. These are abnormal brain growths. It was also linked to infantile spasms, a severe seizure type that starts in infancy (The Transmitter).

The Impact: The findings suggest shared biology between tuberous sclerosis complex and autism. They may help doctors spot which infants face a greater chance of later autism. That could lead to earlier support and monitoring (The Transmitter).

About 40 to 50 percent of people with tuberous sclerosis complex also have autism, according to earlier research. Families may benefit from earlier attention to tuber burden and seizure history (TSC Alliance).

Validity Scorecard:

Sample Size/Demographics: The study followed 125 children for 10 years. That is a modest but useful sample for a rare condition. The summary does not list race, sex, or location. That gap matters because the 40 percent rate and tuber link may not hold across more diverse groups (The Transmitter).
Funding Source: Available coverage does not identify funding. This matters because readers cannot know whether a funder tied to treatment or diagnostics shaped the study’s focus.
Journal Reliability: Epilepsia is a reputable, peer-reviewed Q1 journal in neurology and epilepsy. This supports confidence that the study received specialist review.
ND Involvement: Not disclosed. There is no sign autistic people or their families shaped the study. That matters because researchers framed autism diagnosis as a risk to predict. That framing can affect future coverage and clinical counseling.
Observed Weaknesses: The summary does not describe a control group or statistical methods. It does not say whether researchers adjusted for seizure severity or treatment history. That gap makes it hard to know how much tuber burden alone predicts autism. Seizure severity or early developmental delays may also explain part of the link.

The Facts: Disability Rights Maine urged the state Department of Health and Human Services to move forward with the Lifespan Waiver. The August 17 piece called for a new Medicaid home- and community-based services option. It would serve people with intellectual and developmental disabilities and autism (Disability Rights Maine).

The waiver still needs federal approval from the Centers for Medicare and Medicaid Services. It would replace Maine’s Section 21 and Section 29 waivers with one program (Maine DHHS).

The program would start at age 14 and continue through adulthood. It would avoid the abrupt service “cliff” many people face when children’s services end (Maine DHHS).

The state currently aims for a May 2027 launch. The timing depends on federal approval and state rules (Maine DHHS).

The Impact: Lifespan would add independent-living skills training. It would also add housing start-up help. A wider range of employment support would include help with self-employment (Disability Rights Maine).

Maine’s Section 21 waitlist had more than 2,200 people in mid-2024. Advocates say delay extends the wait for community support. That support can keep people out of institutions (Maine Coalition for Housing & Quality Services).

Institution/Advocacy Scorecard:

Time in Existence: Disability Rights Maine is the state’s federal protection and advocacy organization for disabled people. The Lifespan Waiver project has been in development since at least 2022. That was when DHHS began early information sessions (Disability Rights Maine).
Funding Source: The available piece does not state funding. Disability Rights Maine generally receives federal protection-and-advocacy funding. The piece does not disclose funds for this advocacy effort. That makes it hard to assess whether outside funders shaped its call for faster action.
ND Representation: Not disclosed. The piece does not say whether autistic or IDD self-advocates helped draft the group’s position. That matters because the waiver will shape how autistic Mainers get services throughout life.
Concrete Achievements: The waiver has not launched. No service outcomes exist yet. DHHS has finished public-comment periods and rate-setting hearings. Centers for Medicare and Medicaid Services review remains pending (Maine DHHS). A July 30 Portland Press Herald opinion piece asked DHHS to pause the rollout. The plan remains contested (Portland Press Herald).

See a story we missed? See Tips & Submissions below.

The Facts: Backstage reported August 14 that Netflix confirmed a fifth season of “Love on the Spectrum.” The documentary-style dating series follows autistic and neurodivergent adults (Backstage).

The U.S. version is produced by Australia-based Northern Pictures for Netflix. It has won seven Emmy Awards since its 2022 debut. Those include outstanding unstructured reality program (Backstage).

Northern Pictures’ own casting site is closed. Netflix still accepts applications through its official portal. Applicants must be autistic or neurodivergent adults, age 18 or older, in the United States, Canada, the United Kingdom, or Ireland (Backstage).

The Impact: Co-creator Cian O’Clery said the show aims to introduce viewers to autistic people telling their own stories. Casting producers say they recruit through support groups, employment groups, and community events. They do not rely only on online forms (Backstage).

The show’s long run and Emmy awards have brought autistic dating into mainstream entertainment. Earlier autism portrayals often left out dating and relationships.

The Context/Blindspot: O’Clery has said casting was hard at first. Some potential participants worried a dating show could exploit or sensationalize their experiences (Backstage).

New-season coverage focuses on casting logistics. It does not say much about how prior participants feel after episodes air. It also says little about their longer-term relationship outcomes.

No other new culture or representation story met this cycle’s sourcing bar. Check back next cycle.

See a story we missed? See Tips & Submissions below.

The Facts: The Social Security Administration added 14 conditions to its Compassionate Allowances list on August 11. The list speeds disability benefit approval for people with severe, clearly defined conditions (Social Security Administration).

The list now has 314 qualifying conditions. New entries include Aicardi Syndrome, Bohring-Opitz Syndrome, and CASK-Related Gene Disorders (Disabled World).

These rare genetic and neurological conditions often occur with autism and intellectual disability. They also often include major developmental delays (Disabled World).

The Impact: Compassionate Allowances can approve qualifying claims in days. Standard reviews can take months or years. The listed conditions are considered clearly disabling (Social Security Administration).

Families of children with these conditions may now get Supplemental Security Income faster. They may also get Medicaid-linked disability status sooner. That can help them pay for early intervention and therapy while children are young.

The Context/Blindspot: Coverage has focused on the list itself. It has not examined how many families are managing autism alongside a newly listed condition. It also has not covered how faster approval may interact with Medicaid eligibility redeterminations later this year (KFF).

The change expands a benefit. It does not solve separate federal Medicaid funding cuts now moving through implementation.

No other dated macro event met this cycle’s sourcing bar. Immigration enforcement still poses risks for disabled and autistic children. Pending federal Medicaid funding cuts do, too. Neither produced a new dated development this cycle.

Tips & Submissions: Internet searches do not always find local or international reporting. Know of a story, study, or program? Email links to published reports to autisticafol@gmail.com. Please say if you want credit.

News aggregation and fact-checking tools included internet search engines and AI. Human reviewed and verified.

Divergent Times — August 13–19, 2026

Comments